| Product |
CAS |
Molecular formula |
More |
| Ala-val-ser-glu-his-gln-leu-leu-his-asp-lys-gly-lys-ser-ile-gln-asp-le |
112955-31-4 |
C180H288N58O47 |
More |
| 4-{4-[4-(4-{[(2R,4s)-2-(2,4-dichlorophenyl)-2-(1h-1,2,4-triazol-1-ylme |
112560-33-5 |
C35H36Cl2N8O5 |
More |
| Sodium (z)-1-({2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl] |
112251-56-6 |
C12H18N3NaO4S |
More |
| 4-[(1E)-1-{4-[2-(methylamino)ethoxy]phenyl}-2-phenyl-1-buten-1-yl]phen |
112093-28-4 |
C25H27NO2 |
More |
| (13Z)-13-docosenoic acid methyl ester |
1120-34-9 |
C23H44O2 |
More |
| (1,8-Diethyl-4-oxo-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic ac |
111478-86-5 |
C17H19NO4 |
More |
| Sodium aluminate |
11138-49-1 |
AlNaO2 |
More |
| Calcitonin, rat |
111108-25-5 |
C148H228N40O46S3 |
More |
| 6-Hydroxy-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-1,2,3,9-tetra |
110708-17-3 |
C18H19N3O2 |
More |
| L-cysteinyl-l-alpha-aspartyl-l-prolylglycyl-l-tyrosyl-l-isoleucylglycy |
110590-60-8 |
C40H62N12O14S |
More |
| Angiotensinogen (1-14) (rat) |
110200-37-8 |
C89H123N21O21 |
More |
| N-acetyl-l-leucyl-n-[(1s)-1-formylpentyl]-l-leucinamide |
110044-82-1 |
C20H37N3O4 |
More |
| Taurohyodeoxycholic acid sodium salt |
110026-03-4 |
C26H44NNaO6S |
More |
| 4-[(E)-1-[4-(2-methylaminoethoxy)phenyl]-2-phenylbut-1-enyl]phenol |
110025-28-0 |
C25H27NO2 |
More |
| L-cysteinyl-l-alpha-aspartyl-l-prolylglycyl-l-tyrosyl-l-isoleucylglycy |
110590-61-9 |
C40H63N13O13S |
More |
| Methyl (2-chlorophenyl)(2-oxo-2,6,7,7alpha-tetrahydrothieno[3,2-c]pyri |
109904-27-0 |
C16H16ClNO3S |
More |
| N-hydroxy-n-methyl-2-furamide |
109531-96-6 |
C6H7NO3 |
More |
| NMN zwitterion |
1094-61-7 |
C11H15N2O8P |
More |
| (3R,5r)-rosuvastatin |
1094100-06-7 |
C22H28FN3O6S |
More |
| N-[2-(4-hydroxyphenoxy)-4-nitrophenyl]methanesulfonamide |
109032-22-6 |
C13H12N2O6S |
More |
